Siafis, Spyridon http://orcid.org/0000-0001-8264-2039
Wu, Hui
Wang, Dongfang
Burschinski, Angelika http://orcid.org/0000-0002-1773-6933
Nomura, Nobuyuki
Takeuchi, Hiroyoshi http://orcid.org/0000-0002-8844-4786
Schneider-Thoma, Johannes
Davis, John M. http://orcid.org/0000-0003-3963-1654
Leucht, Stefan
Article History
Received: 14 November 2022
Revised: 17 July 2023
Accepted: 25 July 2023
First Online: 3 August 2023
Competing interests
: In the past 3 years, SL has received honoraria as advisor and/or for lectures and/or for educational material from Alkermes, Angelini, Apsen, Eisai, Gedeon Richter, Janssen, Karuna, Kynexis, Lundbeck, Medichem, Medscape, Merck Sharpp and Dome, Mitshubishi, Neurotorium, NovoNordisk, Otsuka, Recordati, Roche, Rovi, Sanofi Aventis, TEVA. HT has received grants from Daiichi Sankyo and Novartis Pharma; speaker’s fees from EA Pharma, Eisai, Kyowa, Janssen, Lundbeck, Meiji Seika Pharma, MSD, Otsuka, Sumitomo Pharma, Takeda, and Yoshitomiyakuhin; and consulting fees from Janssen, Mitsubishi Tanabe Pharma, Ono, and Sumitomo Pharma. NN has received speaker fees from Meiji Seika Pharma, Otsuka, Eisai, and Sumitomo Pharma, and manuscript fees from Sumitomo Pharma. All the other authors have no conflict of interest to declare.